Results 211 to 220 of about 235,874 (246)

APL

ACM SIGAPL APL Quote Quad, 1974
openaire   +2 more sources

Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study

Lupus, 2014
P. Mustonen, K. Lehtonen, K. Javela, M. Puurunen   +3 more
semanticscholar   +1 more source

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells.

Blood, 1997
G. Chen, X. Shi, W. Tang, S. Xiong, J. Zhu, X. Cai, Z. Han, J. Ni, G. Shi, P. Jia, M. M. Liu, K. He, C. Niu, J. Ma, P. Zhang, T. Zhang, P. Paul, T. Naoe, K. Kitamura, W. Miller, S. Waxman, Z. Wang, H. de Thé, S. Chen, Z. Chen   +24 more
semanticscholar   +1 more source

aPL

2006
  +4 more sources

APLS

Pediatric Emergency Care, 2004
openaire   +1 more source

A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group.

Blood, 1999
P. Fenaux, C. Chastang, S. Chevret, M. Sanz, H. Dombret, E. Archimbaud, M. Fey, C. Rayón, F. Huguet, J. Sotto, C. Gardin, P. C. Makhoul, P. Travade, E. Solary, N. Fegueux, D. Bordessoule, J. Miguel, H. Link, B. Desablens, A. Stamatoullas, E. Deconinck, F. Maloisel, S. Castaigne, C. Preudhomme, L. Degos   +24 more
semanticscholar   +1 more source

APL

Oncology Times, 2007
openaire   +1 more source

APL

Technologies logicielles Architectures des systèmes, 1980
openaire   +1 more source

APL@Voro: A Voronoi-Based Membrane Analysis Tool for GROMACS Trajectories

Journal of Chemical Information and Modeling, 2013
G. Lukat, Jens Krüger, B. Sommer
semanticscholar   +1 more source

APL regulates vascular tissue identity in Arabidopsis

Nature, 2003
Martin Bonke, S. Thitamadee, Ari Pekka Mähönen, M. Hauser, Ykä Helariutta   +4 more
semanticscholar   +1 more source